nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Estropipate—osteoporosis	0.116	0.178	CbGbCtD
Dolasetron—CYP3A4—Estropipate—osteoporosis	0.0676	0.104	CbGbCtD
Dolasetron—CYP3A4—Calcitriol—osteoporosis	0.0676	0.104	CbGbCtD
Dolasetron—CYP2C9—Cholecalciferol—osteoporosis	0.0599	0.0919	CbGbCtD
Dolasetron—CYP2D6—Cholecalciferol—osteoporosis	0.0548	0.084	CbGbCtD
Dolasetron—CYP3A4—Ergocalciferol—osteoporosis	0.0541	0.0829	CbGbCtD
Dolasetron—CYP2C9—Estradiol—osteoporosis	0.0483	0.0741	CbGbCtD
Dolasetron—CYP3A4—Raloxifene—osteoporosis	0.0451	0.0692	CbGbCtD
Dolasetron—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0436	0.0668	CbGbCtD
Dolasetron—CYP3A4—Cholecalciferol—osteoporosis	0.0348	0.0534	CbGbCtD
Dolasetron—CYP3A4—Conjugated Estrogens—osteoporosis	0.032	0.049	CbGbCtD
Dolasetron—CYP3A4—Estradiol—osteoporosis	0.0281	0.0431	CbGbCtD
Dolasetron—Agitation—Zoledronate—osteoporosis	0.000445	0.00128	CcSEcCtD
Dolasetron—Angioedema—Zoledronate—osteoporosis	0.000442	0.00127	CcSEcCtD
Dolasetron—Gastrointestinal pain—Calcitriol—osteoporosis	0.000442	0.00127	CcSEcCtD
Dolasetron—Abdominal pain—Raloxifene—osteoporosis	0.000441	0.00127	CcSEcCtD
Dolasetron—Body temperature increased—Raloxifene—osteoporosis	0.000441	0.00127	CcSEcCtD
Dolasetron—Urticaria—Ibandronate—osteoporosis	0.000439	0.00126	CcSEcCtD
Dolasetron—Malaise—Zoledronate—osteoporosis	0.000437	0.00126	CcSEcCtD
Dolasetron—Body temperature increased—Ibandronate—osteoporosis	0.000437	0.00126	CcSEcCtD
Dolasetron—Abdominal pain—Ibandronate—osteoporosis	0.000437	0.00126	CcSEcCtD
Dolasetron—Confusional state—Pamidronate—osteoporosis	0.000436	0.00125	CcSEcCtD
Dolasetron—Vertigo—Zoledronate—osteoporosis	0.000435	0.00125	CcSEcCtD
Dolasetron—Syncope—Zoledronate—osteoporosis	0.000434	0.00125	CcSEcCtD
Dolasetron—Anaphylactic shock—Pamidronate—osteoporosis	0.000433	0.00124	CcSEcCtD
Dolasetron—Oedema—Pamidronate—osteoporosis	0.000433	0.00124	CcSEcCtD
Dolasetron—Urticaria—Calcitriol—osteoporosis	0.000429	0.00123	CcSEcCtD
Dolasetron—Palpitations—Zoledronate—osteoporosis	0.000428	0.00123	CcSEcCtD
Dolasetron—Abdominal pain—Calcitriol—osteoporosis	0.000427	0.00123	CcSEcCtD
Dolasetron—Body temperature increased—Calcitriol—osteoporosis	0.000427	0.00123	CcSEcCtD
Dolasetron—Angioedema—Conjugated Estrogens—osteoporosis	0.000426	0.00122	CcSEcCtD
Dolasetron—Shock—Pamidronate—osteoporosis	0.000426	0.00122	CcSEcCtD
Dolasetron—Loss of consciousness—Zoledronate—osteoporosis	0.000426	0.00122	CcSEcCtD
Dolasetron—Hypersensitivity—Estropipate—osteoporosis	0.000424	0.00122	CcSEcCtD
Dolasetron—Thrombocytopenia—Pamidronate—osteoporosis	0.000424	0.00122	CcSEcCtD
Dolasetron—Cough—Zoledronate—osteoporosis	0.000423	0.00121	CcSEcCtD
Dolasetron—Oedema peripheral—Estradiol—osteoporosis	0.000422	0.00121	CcSEcCtD
Dolasetron—Tachycardia—Pamidronate—osteoporosis	0.000422	0.00121	CcSEcCtD
Dolasetron—Rash—Etidronic acid—osteoporosis	0.00042	0.00121	CcSEcCtD
Dolasetron—Convulsion—Zoledronate—osteoporosis	0.00042	0.00121	CcSEcCtD
Dolasetron—Dermatitis—Etidronic acid—osteoporosis	0.000419	0.00121	CcSEcCtD
Dolasetron—Vertigo—Conjugated Estrogens—osteoporosis	0.000419	0.0012	CcSEcCtD
Dolasetron—Hyperhidrosis—Pamidronate—osteoporosis	0.000418	0.0012	CcSEcCtD
Dolasetron—Syncope—Conjugated Estrogens—osteoporosis	0.000418	0.0012	CcSEcCtD
Dolasetron—Hypertension—Zoledronate—osteoporosis	0.000418	0.0012	CcSEcCtD
Dolasetron—Hypersensitivity—Alendronate—osteoporosis	0.000418	0.0012	CcSEcCtD
Dolasetron—Headache—Etidronic acid—osteoporosis	0.000417	0.0012	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000415	0.00119	CcSEcCtD
Dolasetron—Asthenia—Estropipate—osteoporosis	0.000413	0.00119	CcSEcCtD
Dolasetron—Visual impairment—Estradiol—osteoporosis	0.000413	0.00119	CcSEcCtD
Dolasetron—Anorexia—Pamidronate—osteoporosis	0.000412	0.00119	CcSEcCtD
Dolasetron—Arthralgia—Zoledronate—osteoporosis	0.000412	0.00119	CcSEcCtD
Dolasetron—Chest pain—Zoledronate—osteoporosis	0.000412	0.00119	CcSEcCtD
Dolasetron—Myalgia—Zoledronate—osteoporosis	0.000412	0.00119	CcSEcCtD
Dolasetron—Palpitations—Conjugated Estrogens—osteoporosis	0.000412	0.00118	CcSEcCtD
Dolasetron—Anxiety—Zoledronate—osteoporosis	0.000411	0.00118	CcSEcCtD
Dolasetron—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00041	0.00118	CcSEcCtD
Dolasetron—Paraesthesia—Risedronate—osteoporosis	0.000409	0.00118	CcSEcCtD
Dolasetron—Pruritus—Estropipate—osteoporosis	0.000407	0.00117	CcSEcCtD
Dolasetron—Discomfort—Zoledronate—osteoporosis	0.000407	0.00117	CcSEcCtD
Dolasetron—Asthenia—Alendronate—osteoporosis	0.000407	0.00117	CcSEcCtD
Dolasetron—Hypersensitivity—Ibandronate—osteoporosis	0.000407	0.00117	CcSEcCtD
Dolasetron—Cough—Conjugated Estrogens—osteoporosis	0.000407	0.00117	CcSEcCtD
Dolasetron—Dyspnoea—Risedronate—osteoporosis	0.000406	0.00117	CcSEcCtD
Dolasetron—Hypotension—Pamidronate—osteoporosis	0.000404	0.00116	CcSEcCtD
Dolasetron—Convulsion—Conjugated Estrogens—osteoporosis	0.000404	0.00116	CcSEcCtD
Dolasetron—Dry mouth—Zoledronate—osteoporosis	0.000403	0.00116	CcSEcCtD
Dolasetron—Fatigue—Ethinyl Estradiol—osteoporosis	0.000402	0.00116	CcSEcCtD
Dolasetron—Pruritus—Alendronate—osteoporosis	0.000401	0.00115	CcSEcCtD
Dolasetron—Dyspepsia—Risedronate—osteoporosis	0.000401	0.00115	CcSEcCtD
Dolasetron—Tinnitus—Estradiol—osteoporosis	0.0004	0.00115	CcSEcCtD
Dolasetron—Constipation—Ethinyl Estradiol—osteoporosis	0.000399	0.00115	CcSEcCtD
Dolasetron—Confusional state—Zoledronate—osteoporosis	0.000398	0.00115	CcSEcCtD
Dolasetron—Hypersensitivity—Calcitriol—osteoporosis	0.000398	0.00115	CcSEcCtD
Dolasetron—Flushing—Estradiol—osteoporosis	0.000398	0.00114	CcSEcCtD
Dolasetron—Chest pain—Conjugated Estrogens—osteoporosis	0.000397	0.00114	CcSEcCtD
Dolasetron—Arthralgia—Conjugated Estrogens—osteoporosis	0.000397	0.00114	CcSEcCtD
Dolasetron—Myalgia—Conjugated Estrogens—osteoporosis	0.000397	0.00114	CcSEcCtD
Dolasetron—Asthenia—Ibandronate—osteoporosis	0.000396	0.00114	CcSEcCtD
Dolasetron—Anxiety—Conjugated Estrogens—osteoporosis	0.000396	0.00114	CcSEcCtD
Dolasetron—Anaphylactic shock—Zoledronate—osteoporosis	0.000395	0.00114	CcSEcCtD
Dolasetron—Oedema—Zoledronate—osteoporosis	0.000395	0.00114	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000394	0.00113	CcSEcCtD
Dolasetron—Diarrhoea—Estropipate—osteoporosis	0.000394	0.00113	CcSEcCtD
Dolasetron—Fatigue—Risedronate—osteoporosis	0.000392	0.00113	CcSEcCtD
Dolasetron—Pruritus—Ibandronate—osteoporosis	0.000391	0.00112	CcSEcCtD
Dolasetron—Constipation—Risedronate—osteoporosis	0.000389	0.00112	CcSEcCtD
Dolasetron—Pain—Risedronate—osteoporosis	0.000389	0.00112	CcSEcCtD
Dolasetron—Shock—Zoledronate—osteoporosis	0.000389	0.00112	CcSEcCtD
Dolasetron—Paraesthesia—Pamidronate—osteoporosis	0.000388	0.00112	CcSEcCtD
Dolasetron—Diarrhoea—Alendronate—osteoporosis	0.000388	0.00112	CcSEcCtD
Dolasetron—Asthenia—Calcitriol—osteoporosis	0.000388	0.00112	CcSEcCtD
Dolasetron—Thrombocytopenia—Zoledronate—osteoporosis	0.000387	0.00111	CcSEcCtD
Dolasetron—Dyspnoea—Pamidronate—osteoporosis	0.000386	0.00111	CcSEcCtD
Dolasetron—Tachycardia—Zoledronate—osteoporosis	0.000386	0.00111	CcSEcCtD
Dolasetron—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000385	0.00111	CcSEcCtD
Dolasetron—Chills—Estradiol—osteoporosis	0.000385	0.00111	CcSEcCtD
Dolasetron—Somnolence—Pamidronate—osteoporosis	0.000385	0.00111	CcSEcCtD
Dolasetron—Pruritus—Calcitriol—osteoporosis	0.000382	0.0011	CcSEcCtD
Dolasetron—Hyperhidrosis—Zoledronate—osteoporosis	0.000382	0.0011	CcSEcCtD
Dolasetron—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000382	0.0011	CcSEcCtD
Dolasetron—Diarrhoea—Raloxifene—osteoporosis	0.000382	0.0011	CcSEcCtD
Dolasetron—Dyspepsia—Pamidronate—osteoporosis	0.000381	0.0011	CcSEcCtD
Dolasetron—Dizziness—Estropipate—osteoporosis	0.000381	0.00109	CcSEcCtD
Dolasetron—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00038	0.00109	CcSEcCtD
Dolasetron—Oedema—Conjugated Estrogens—osteoporosis	0.00038	0.00109	CcSEcCtD
Dolasetron—Diarrhoea—Ibandronate—osteoporosis	0.000378	0.00109	CcSEcCtD
Dolasetron—Anorexia—Zoledronate—osteoporosis	0.000377	0.00108	CcSEcCtD
Dolasetron—Decreased appetite—Pamidronate—osteoporosis	0.000376	0.00108	CcSEcCtD
Dolasetron—Dizziness—Alendronate—osteoporosis	0.000375	0.00108	CcSEcCtD
Dolasetron—Shock—Conjugated Estrogens—osteoporosis	0.000374	0.00108	CcSEcCtD
Dolasetron—Fatigue—Pamidronate—osteoporosis	0.000373	0.00107	CcSEcCtD
Dolasetron—Gastrointestinal pain—Risedronate—osteoporosis	0.000372	0.00107	CcSEcCtD
Dolasetron—Tachycardia—Conjugated Estrogens—osteoporosis	0.000371	0.00107	CcSEcCtD
Dolasetron—Urticaria—Ethinyl Estradiol—osteoporosis	0.000371	0.00107	CcSEcCtD
Dolasetron—Pain—Pamidronate—osteoporosis	0.00037	0.00106	CcSEcCtD
Dolasetron—Constipation—Pamidronate—osteoporosis	0.00037	0.00106	CcSEcCtD
Dolasetron—Diarrhoea—Calcitriol—osteoporosis	0.00037	0.00106	CcSEcCtD
Dolasetron—Hypotension—Zoledronate—osteoporosis	0.000369	0.00106	CcSEcCtD
Dolasetron—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000369	0.00106	CcSEcCtD
Dolasetron—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000369	0.00106	CcSEcCtD
Dolasetron—Dizziness—Raloxifene—osteoporosis	0.000369	0.00106	CcSEcCtD
Dolasetron—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000368	0.00106	CcSEcCtD
Dolasetron—Flatulence—Estradiol—osteoporosis	0.000368	0.00106	CcSEcCtD
Dolasetron—Dysgeusia—Estradiol—osteoporosis	0.000365	0.00105	CcSEcCtD
Dolasetron—Dizziness—Ibandronate—osteoporosis	0.000365	0.00105	CcSEcCtD
Dolasetron—Rash—Estropipate—osteoporosis	0.000363	0.00104	CcSEcCtD
Dolasetron—Dermatitis—Estropipate—osteoporosis	0.000363	0.00104	CcSEcCtD
Dolasetron—Anorexia—Conjugated Estrogens—osteoporosis	0.000363	0.00104	CcSEcCtD
Dolasetron—Urticaria—Risedronate—osteoporosis	0.000362	0.00104	CcSEcCtD
Dolasetron—Headache—Estropipate—osteoporosis	0.000361	0.00104	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00036	0.00104	CcSEcCtD
Dolasetron—Abdominal pain—Risedronate—osteoporosis	0.00036	0.00103	CcSEcCtD
Dolasetron—Body temperature increased—Risedronate—osteoporosis	0.00036	0.00103	CcSEcCtD
Dolasetron—Rash—Alendronate—osteoporosis	0.000358	0.00103	CcSEcCtD
Dolasetron—Dermatitis—Alendronate—osteoporosis	0.000357	0.00103	CcSEcCtD
Dolasetron—Feeling abnormal—Pamidronate—osteoporosis	0.000356	0.00103	CcSEcCtD
Dolasetron—Hypotension—Conjugated Estrogens—osteoporosis	0.000356	0.00102	CcSEcCtD
Dolasetron—Headache—Alendronate—osteoporosis	0.000355	0.00102	CcSEcCtD
Dolasetron—Paraesthesia—Zoledronate—osteoporosis	0.000355	0.00102	CcSEcCtD
Dolasetron—Gastrointestinal pain—Pamidronate—osteoporosis	0.000354	0.00102	CcSEcCtD
Dolasetron—Dyspnoea—Zoledronate—osteoporosis	0.000352	0.00101	CcSEcCtD
Dolasetron—Rash—Raloxifene—osteoporosis	0.000352	0.00101	CcSEcCtD
Dolasetron—Dermatitis—Raloxifene—osteoporosis	0.000351	0.00101	CcSEcCtD
Dolasetron—Somnolence—Zoledronate—osteoporosis	0.000351	0.00101	CcSEcCtD
Dolasetron—Tremor—Estradiol—osteoporosis	0.00035	0.00101	CcSEcCtD
Dolasetron—Headache—Raloxifene—osteoporosis	0.000349	0.001	CcSEcCtD
Dolasetron—Rash—Ibandronate—osteoporosis	0.000348	0.001	CcSEcCtD
Dolasetron—Dermatitis—Ibandronate—osteoporosis	0.000348	0.001	CcSEcCtD
Dolasetron—Dyspepsia—Zoledronate—osteoporosis	0.000348	0.001	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000347	0.000997	CcSEcCtD
Dolasetron—Ill-defined disorder—Estradiol—osteoporosis	0.000346	0.000996	CcSEcCtD
Dolasetron—Headache—Ibandronate—osteoporosis	0.000346	0.000995	CcSEcCtD
Dolasetron—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000344	0.000989	CcSEcCtD
Dolasetron—Decreased appetite—Zoledronate—osteoporosis	0.000344	0.000988	CcSEcCtD
Dolasetron—Agitation—Estradiol—osteoporosis	0.000343	0.000986	CcSEcCtD
Dolasetron—Abdominal pain—Pamidronate—osteoporosis	0.000342	0.000983	CcSEcCtD
Dolasetron—Body temperature increased—Pamidronate—osteoporosis	0.000342	0.000983	CcSEcCtD
Dolasetron—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000342	0.000982	CcSEcCtD
Dolasetron—Angioedema—Estradiol—osteoporosis	0.000341	0.00098	CcSEcCtD
Dolasetron—Rash—Calcitriol—osteoporosis	0.000341	0.00098	CcSEcCtD
Dolasetron—Fatigue—Zoledronate—osteoporosis	0.000341	0.00098	CcSEcCtD
Dolasetron—Dermatitis—Calcitriol—osteoporosis	0.000341	0.000979	CcSEcCtD
Dolasetron—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000339	0.000975	CcSEcCtD
Dolasetron—Headache—Calcitriol—osteoporosis	0.000339	0.000974	CcSEcCtD
Dolasetron—Somnolence—Conjugated Estrogens—osteoporosis	0.000338	0.000973	CcSEcCtD
Dolasetron—Pain—Zoledronate—osteoporosis	0.000338	0.000972	CcSEcCtD
Dolasetron—Constipation—Zoledronate—osteoporosis	0.000338	0.000972	CcSEcCtD
Dolasetron—Malaise—Estradiol—osteoporosis	0.000336	0.000968	CcSEcCtD
Dolasetron—Hypersensitivity—Risedronate—osteoporosis	0.000335	0.000964	CcSEcCtD
Dolasetron—Vertigo—Estradiol—osteoporosis	0.000335	0.000964	CcSEcCtD
Dolasetron—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000335	0.000963	CcSEcCtD
Dolasetron—Asthenia—Ethinyl Estradiol—osteoporosis	0.000335	0.000963	CcSEcCtD
Dolasetron—Syncope—Estradiol—osteoporosis	0.000335	0.000962	CcSEcCtD
Dolasetron—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000331	0.000951	CcSEcCtD
Dolasetron—Pruritus—Ethinyl Estradiol—osteoporosis	0.00033	0.00095	CcSEcCtD
Dolasetron—Palpitations—Estradiol—osteoporosis	0.00033	0.000948	CcSEcCtD
Dolasetron—Fatigue—Conjugated Estrogens—osteoporosis	0.000328	0.000943	CcSEcCtD
Dolasetron—Loss of consciousness—Estradiol—osteoporosis	0.000328	0.000943	CcSEcCtD
Dolasetron—Asthenia—Risedronate—osteoporosis	0.000327	0.000939	CcSEcCtD
Dolasetron—Feeling abnormal—Zoledronate—osteoporosis	0.000326	0.000936	CcSEcCtD
Dolasetron—Cough—Estradiol—osteoporosis	0.000326	0.000936	CcSEcCtD
Dolasetron—Pain—Conjugated Estrogens—osteoporosis	0.000325	0.000936	CcSEcCtD
Dolasetron—Constipation—Conjugated Estrogens—osteoporosis	0.000325	0.000936	CcSEcCtD
Dolasetron—Gastrointestinal pain—Zoledronate—osteoporosis	0.000323	0.000929	CcSEcCtD
Dolasetron—Hypertension—Estradiol—osteoporosis	0.000322	0.000926	CcSEcCtD
Dolasetron—Pruritus—Risedronate—osteoporosis	0.000322	0.000926	CcSEcCtD
Dolasetron—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000319	0.000918	CcSEcCtD
Dolasetron—Hypersensitivity—Pamidronate—osteoporosis	0.000319	0.000917	CcSEcCtD
Dolasetron—Chest pain—Estradiol—osteoporosis	0.000318	0.000913	CcSEcCtD
Dolasetron—Arthralgia—Estradiol—osteoporosis	0.000318	0.000913	CcSEcCtD
Dolasetron—Myalgia—Estradiol—osteoporosis	0.000318	0.000913	CcSEcCtD
Dolasetron—Anxiety—Estradiol—osteoporosis	0.000317	0.00091	CcSEcCtD
Dolasetron—Urticaria—Zoledronate—osteoporosis	0.000314	0.000903	CcSEcCtD
Dolasetron—Discomfort—Estradiol—osteoporosis	0.000314	0.000903	CcSEcCtD
Dolasetron—Abdominal pain—Zoledronate—osteoporosis	0.000312	0.000898	CcSEcCtD
Dolasetron—Body temperature increased—Zoledronate—osteoporosis	0.000312	0.000898	CcSEcCtD
Dolasetron—Diarrhoea—Risedronate—osteoporosis	0.000311	0.000895	CcSEcCtD
Dolasetron—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000311	0.000895	CcSEcCtD
Dolasetron—Dry mouth—Estradiol—osteoporosis	0.000311	0.000893	CcSEcCtD
Dolasetron—Asthenia—Pamidronate—osteoporosis	0.00031	0.000893	CcSEcCtD
Dolasetron—Dizziness—Ethinyl Estradiol—osteoporosis	0.000309	0.000888	CcSEcCtD
Dolasetron—Confusional state—Estradiol—osteoporosis	0.000307	0.000883	CcSEcCtD
Dolasetron—Pruritus—Pamidronate—osteoporosis	0.000306	0.00088	CcSEcCtD
Dolasetron—Anaphylactic shock—Estradiol—osteoporosis	0.000305	0.000876	CcSEcCtD
Dolasetron—Oedema—Estradiol—osteoporosis	0.000305	0.000876	CcSEcCtD
Dolasetron—Urticaria—Conjugated Estrogens—osteoporosis	0.000302	0.000869	CcSEcCtD
Dolasetron—Dizziness—Risedronate—osteoporosis	0.000301	0.000865	CcSEcCtD
Dolasetron—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000301	0.000865	CcSEcCtD
Dolasetron—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000301	0.000865	CcSEcCtD
Dolasetron—Shock—Estradiol—osteoporosis	0.0003	0.000862	CcSEcCtD
Dolasetron—Tachycardia—Estradiol—osteoporosis	0.000297	0.000855	CcSEcCtD
Dolasetron—Diarrhoea—Pamidronate—osteoporosis	0.000296	0.000851	CcSEcCtD
Dolasetron—Hyperhidrosis—Estradiol—osteoporosis	0.000294	0.000847	CcSEcCtD
Dolasetron—Rash—Ethinyl Estradiol—osteoporosis	0.000294	0.000846	CcSEcCtD
Dolasetron—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000294	0.000845	CcSEcCtD
Dolasetron—Headache—Ethinyl Estradiol—osteoporosis	0.000292	0.000841	CcSEcCtD
Dolasetron—Hypersensitivity—Zoledronate—osteoporosis	0.000291	0.000837	CcSEcCtD
Dolasetron—Rash—Risedronate—osteoporosis	0.000287	0.000825	CcSEcCtD
Dolasetron—Dermatitis—Risedronate—osteoporosis	0.000287	0.000824	CcSEcCtD
Dolasetron—Dizziness—Pamidronate—osteoporosis	0.000286	0.000823	CcSEcCtD
Dolasetron—Headache—Risedronate—osteoporosis	0.000285	0.00082	CcSEcCtD
Dolasetron—Asthenia—Zoledronate—osteoporosis	0.000284	0.000815	CcSEcCtD
Dolasetron—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00028	0.000806	CcSEcCtD
Dolasetron—Pruritus—Zoledronate—osteoporosis	0.00028	0.000804	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000277	0.000798	CcSEcCtD
Dolasetron—Paraesthesia—Estradiol—osteoporosis	0.000273	0.000786	CcSEcCtD
Dolasetron—Asthenia—Conjugated Estrogens—osteoporosis	0.000273	0.000785	CcSEcCtD
Dolasetron—Rash—Pamidronate—osteoporosis	0.000273	0.000784	CcSEcCtD
Dolasetron—Dermatitis—Pamidronate—osteoporosis	0.000273	0.000784	CcSEcCtD
Dolasetron—Dyspnoea—Estradiol—osteoporosis	0.000271	0.000781	CcSEcCtD
Dolasetron—Headache—Pamidronate—osteoporosis	0.000271	0.000779	CcSEcCtD
Dolasetron—Somnolence—Estradiol—osteoporosis	0.000271	0.000778	CcSEcCtD
Dolasetron—Diarrhoea—Zoledronate—osteoporosis	0.00027	0.000777	CcSEcCtD
Dolasetron—Pruritus—Conjugated Estrogens—osteoporosis	0.000269	0.000774	CcSEcCtD
Dolasetron—Dyspepsia—Estradiol—osteoporosis	0.000268	0.000771	CcSEcCtD
Dolasetron—Decreased appetite—Estradiol—osteoporosis	0.000265	0.000761	CcSEcCtD
Dolasetron—Fatigue—Estradiol—osteoporosis	0.000263	0.000755	CcSEcCtD
Dolasetron—Dizziness—Zoledronate—osteoporosis	0.000261	0.000751	CcSEcCtD
Dolasetron—Pain—Estradiol—osteoporosis	0.00026	0.000749	CcSEcCtD
Dolasetron—Constipation—Estradiol—osteoporosis	0.00026	0.000749	CcSEcCtD
Dolasetron—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00026	0.000749	CcSEcCtD
Dolasetron—Dizziness—Conjugated Estrogens—osteoporosis	0.000252	0.000724	CcSEcCtD
Dolasetron—Feeling abnormal—Estradiol—osteoporosis	0.000251	0.000722	CcSEcCtD
Dolasetron—Rash—Zoledronate—osteoporosis	0.000249	0.000716	CcSEcCtD
Dolasetron—Gastrointestinal pain—Estradiol—osteoporosis	0.000249	0.000716	CcSEcCtD
Dolasetron—Dermatitis—Zoledronate—osteoporosis	0.000249	0.000716	CcSEcCtD
Dolasetron—Headache—Zoledronate—osteoporosis	0.000248	0.000712	CcSEcCtD
Dolasetron—Urticaria—Estradiol—osteoporosis	0.000242	0.000696	CcSEcCtD
Dolasetron—Abdominal pain—Estradiol—osteoporosis	0.000241	0.000692	CcSEcCtD
Dolasetron—Body temperature increased—Estradiol—osteoporosis	0.000241	0.000692	CcSEcCtD
Dolasetron—Rash—Conjugated Estrogens—osteoporosis	0.00024	0.00069	CcSEcCtD
Dolasetron—Dermatitis—Conjugated Estrogens—osteoporosis	0.00024	0.000689	CcSEcCtD
Dolasetron—Headache—Conjugated Estrogens—osteoporosis	0.000238	0.000685	CcSEcCtD
Dolasetron—Hypersensitivity—Estradiol—osteoporosis	0.000224	0.000645	CcSEcCtD
Dolasetron—Asthenia—Estradiol—osteoporosis	0.000218	0.000628	CcSEcCtD
Dolasetron—Pruritus—Estradiol—osteoporosis	0.000215	0.00062	CcSEcCtD
Dolasetron—Diarrhoea—Estradiol—osteoporosis	0.000208	0.000599	CcSEcCtD
Dolasetron—Dizziness—Estradiol—osteoporosis	0.000201	0.000579	CcSEcCtD
Dolasetron—Rash—Estradiol—osteoporosis	0.000192	0.000552	CcSEcCtD
Dolasetron—Dermatitis—Estradiol—osteoporosis	0.000192	0.000552	CcSEcCtD
Dolasetron—Headache—Estradiol—osteoporosis	0.000191	0.000549	CcSEcCtD
